• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Biophysical Chemistry: An International Journal Devoted to the Physical Chemistry of Biological Phenomena >Mathematical model of NO and O2 transport in an arteriole facilitated by hemoglobin based O2 carriers.
【24h】

Mathematical model of NO and O2 transport in an arteriole facilitated by hemoglobin based O2 carriers.

机译：基于血红蛋白的O2载体促进了小动脉中NO和O2转运的数学模型。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The increasing demand for donated human blood has spurred research to develop hemoglobin-based O(2) carriers (HBOCs) that can be used as red blood cell (RBC) substitutes. However, in vivo studies of acellular HBOCs have shown an increase in mean arterial pressure following transfusion that has been attributed to the HBOC's ability to scavenge NO (an important vasodilator that is synthesized by endothelial cells in the blood vessel wall that signals neighboring smooth muscle cells to relax). In this study, a mathematical model was developed to describe NO and O(2) transport in an arteriole containing a mixture of acellular HBOCs and RBCs. The acellular HBOCs studied in this work possessed a wide range of O(2) affinities, O(2) dissociation rate constants and NO reactivities in order to evaluate their effect on O(2) tension and NO concentration in the arteriole tissue region. By focusing on the concentration of NO that is localized in the arteriole smooth muscle cell region, the model can predict the vasopressor response of HBOCs. The results of this study confirmed that acellular HBOCs scavenge large amounts of NO from the entire arteriole (approximately 50% or more NO compared to RBCs only). A recombinant Hb, rHb3011, displayed the least NO reactivity and consequently left the most NO remaining in the arteriole. The NO concentration in the arteriole with respect to the other HBOCs studied was proportional to their NO reactivity. Therefore, the results of this study demonstrate that NO scavenging is an unavoidable consequence of transfusing HBOCs. To prevent or reduce vasodilatation, we suggest administration of NO by either inhaling NO or transfusing nitrite into the blood stream followed by transfusion of HBOC.
机译：对捐赠的人类血液的需求不断增加，促使人们开发基于血红蛋白的O（2）携带者（HBOC）用作红细胞（RBC）替代品。但是，对脱细胞HBOC的体内研究表明，输血后平均动脉压升高，这归因于HBOC清除NO的能力（一种重要的血管扩张剂，由血管壁中的内皮细胞合成，向邻近的平滑肌细胞发出信号放松）。在这项研究中，建立了一个数学模型来描述NO和O（2）在包含无细胞HBOC和RBC混合物的小动脉中的运输。在这项工作中研究的脱细胞HBOC具有广泛的O（2）亲和力，O（2）解离速率常数和NO反应性，以评估它们对小动脉组织区域中O（2）张力和NO浓度的影响。通过关注位于小动脉平滑肌细胞区域中的NO浓度，该模型可以预测HBOC的血管升压反应。这项研究的结果证实，脱细胞的HBOC可清除整个小动脉中的大量NO（与仅RBC相比，约占50％或更多）。重组Hb rHb3011显示最低的NO反应性，因此留在小动脉中的NO最多。相对于其他研究的HBOC，小动脉中的NO浓度与其NO反应性成正比。因此，这项研究的结果表明，清除NO是清除HBOC的不可避免结果。为预防或减少血管舒张，我们建议通过吸入NO或将亚硝酸盐输入血流，然后输注HBOC来给予NO。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号